Goal 3: Good Health and Well-Being
 |
McMaster researcher Gerry Wright is a trailblazer in antimicrobial discovery, leading the global fight against superbugs and antibiotic resistance. He leads a global network that is working to prevent future pandemics as part of SDG 3. |
Preventing A SLOW-MOVING CATASTROPHE
Antibiotics are essential to modern medicine. We rely on them to cure everything from pneumonia to meningitis. The infection control they provide makes life-saving treatments like cancer chemotherapy and heart transplants possible.
But widespread overuse of these drugs in agriculture and medicine have led bacteria to evolve, increasing resistance to penicillin and related medicines. Antibiotic resistance causes 700,000 deaths globally each year – a number that’s expected to rise to 10 million by 2050.
The stakes couldn’t be higher.
That’s why infectious disease expert Gerry Wright is working with teams of researchers to understand and detect antimicrobial resistance, and develop new treatments to stop this global threat in its tracks.
Featured Stories
McMaster researchers discover unusual bacteria-killing toxin
McMaster researchers have discovered a previously unknown bacteria-killing toxin that could pave the way for a new generation of antibiotics. The study, led by John . . .
Ten McMaster professors elected fellows of Canadian Academy of Health Sciences
Nine professors of the Faculty of Health Sciences and one from the Faculty of Science are joining the Canadian Academy of Health Sciences (CAHS) as . . .
McMaster symposium to bring together international experts on antimicrobial resistance
Researchers from Canada’s Global Nexus for Pandemics and Biological Threats are bringing international experts to McMaster next month for an interdisciplinary symposium aimed at solutions . . .
Discover how Our Research is making an Impact
